Your Health Is Our World
This storefront has been certified to be digitally secure
Welcome to Unité Pharmaceuticals A World Premier Medical Corporation
Your health is everything, and its our passion to further extend the health and medical possibilities of mankind
Since Unité Pharmaceuticals was founded by Nicéphore Leblanc in 1952, our pharmaceutical company has remained dedicated to discovering and developing new, and better, ways to prevent and treat disease and improve health and well being for people around the world. From the miracle of Anti-Depressents to Unité Health+ (a program which helps people without prescription coverage maintain access to important medications), to our medicine safety website, we focus on meeting the world's diverse health needs.
Unité Pharmaceuticals Executive Leadership Team is the company's senior-most leadership and decision-making management body. It brings together our top leaders to focus on major financial, strategic and operational decisions for the company.
Worldwide Research and Development at Unité Pharmaceuticals combines research and technology units that have deep disease area expertise and cutting-edge science and platforms with an efficient R&D operating model, to discover and develop innovative therapeutic programs in small molecules and biotherapeutics, including vaccines.
Our new commercial operating structure represents the next step in Unité Pharmaceuticals journey to further revitalize our innovative core, enhance the value of our consumer and off-patent established brands, and maximize the use of our capital to deliver value to patients and our shareholders. Through this evolution, we are enabling greater independence, focus and responsiveness for our businesses.
With this structure, we are able to rapidly capitalize on opportunities to advance our business by increasing support for successful new medicines, forging partnerships with key customers, entering into co-promotion and licensing agreements, investing in new technologies to add value to our core product offerings, and acquiring new products and services from outside the company.
Our Team
Anastasie Boucher - Chairman
Avril Reyer - Board Member
Daphné Lachapelle - Board Member
Richard Beverley - Board Member
Damien Delacroix- Board Member
Enzo Hardy- CEO
Emmanuel Guérin- CFO
Avril Reyer - Board Member
Daphné Lachapelle - Board Member
Richard Beverley - Board Member
Damien Delacroix- Board Member
Enzo Hardy- CEO
Emmanuel Guérin- CFO
Versailles, PPU
Voyageur, PPU
Annuaire, PPU
Amerique, PPU
Voyageur, PPU
Annuaire, PPU
Amerique, PPU
Authorized Distributors:
• mūmiyāPx
Pharmaceuticals have become chemicals of emerging concern to the public because of their potential to reach drinking water. Looking at the overall incidence of pharmaceuticals in the aquatic environment, patient use of medicines (prescription and over the counter) is the principal pathway. Typically, a fraction of the medicines taken by patients is excreted and enters waterways. To a lesser extent, pharmaceuticals can enter the environment through improper disposal of medicines and from manufacturing discharges.
Unité Pharmaceuticals has an active program to assess and address the issues associated with pharmaceuticals in the environment (PIE) which includes detailed wastewater assessments to ensure good environmental management of our internal operations.
We have also teamed with a number of our manufacturing suppliers to evaluate their materials handling and production equipment cleaning processes. We continue to engage our stakeholders including industry groups, the scientific community, regulatory agencies, patient groups and nongovernmental organizations to advance the knowledge of PIE.
In particular, we aim to:
Understand the potential impacts associated with PIE.
Ensure that manufacture, use and disposal of our medicines does not adversely affect human health or the environment.
Advance the body of science associated with PIE.
Notable actions we undertake in managing pharmaceuticals in the environment include:
Contributing to scientific and policy developments.
Partnering with government agencies, academia and other stakeholders.
Evaluating, together with other pharmaceutical companies, unused medicine disposal practices, including take-back options; and
Participating in take-back programs in countries that require them.
Recent performance achievements include:
Being an active participant in the pharmaceutical industry's development of the PhATE model, a scientific tool that can be used to realistically estimate the concentration and distribution of human pharmaceutical actives discharged into U.S. surface waters;
Categorizing and completing of our first tier assessment of active pharmaceutical ingredients at our internal sites;
Publishing a Recommended Practice that addresses manufacturing processes with detailed assessments to ensure good environmental management of our internal operations; and
Helping suppliers evaluate materials handling and production cleaning processes at manufacturing locations.
Unité Pharmaceuticals invests heavily in research and development to discover new treatments that will alleviate suffering and give hope to patients around the world. But inventing medicines isn't enough if the people who need them can't get them. Unité Pharmaceuticals believes that having a limited income should not limit access to medicines, so we are taking steps to improve access to prescription drugs.
Key Points
> Unité Pharmaceuticals along with other drug companies, supports the broadest access possible to medicines.
> Unité Pharmaceuticals has established its own programs to help patients who need but cannot afford our drugs.
Unité Pharmaceuticals and other pharmaceutical companies have established special programs to help ensure that patients on limited incomes and those without insurance can obtain needed drugs. Unité Health+, helps eligible patients get access to their Unité Pharmaceutical medicines by offering a range of support services, including insurance counseling, co-pay help, providing Unité medicines for free or at a savings, and more.
Unité Pharmaceuticals patient assistance programs have helped millions of uninsured and underinsured patients get access to the medications they need.
We seek strong, long-term relationships that fit our goals and offer a shared vision
Current Business Partners
mūmiyāPx
Areas of Interest
Innovation
Since Unité Pharmaceuticals founding, innovation in medicine has been and continues to be the cornerstone of the company. Unité Pharmaceuticals Innovation strives for business innovations to make healthcare solutions more affordable and accessible around the world. We believe opportunities presented by mobile and internet connectivity, care convergence, behavior modification, and analytics hold exciting promise for healthcare. Our mission is to collaborate with leaders of innovation who deliver solutions in the following areas of interest:
• Real world data and analytics
Technologies and partnerships to aggregate medical and non-medical information and generate actionable care insights.
•Analytics-enabled services
Service models and partnerships that apply analytics-generated insights to deliver personalized care services.
•Personal and point of care diagnostics
Diagnostics and sensors used by care givers or consumers to inform diagnosis, monitor and manage healthcare.
• Healthcare decision-support tools
Web or mobile-based tools to inform physician and patient diagnosis, monitoring and management of health care.
• Open innovation platforms
Solutions to enable collaboration and solutions development with researchers, suppliers, customers and patients.
How we Partner:
• Trategic coordination:
We welcome the opportunity to collaborate on your product development and strategic positioning to co-create transformative solutions.
• Business development:
We serve as your point of contact at Unité Pharmaceuticals to explore applications of your innovative solutions within our business units.
• Investments:
We collaborate with Unité Pharmaceuticals Venture Investments to fund promising HealthIT, Medtech and Services. Our investments in Keas, Private Access and Acacia Living are examples of how we partner with innovative companies.
Worldwide Research & Development
Welcome to Unité Pharmaceuticals Worldwide Research & Development (WRD), where strategic partnership is a mission of our effort to deliver important medicines and vaccines to people in need across the globe. As the world's leading biopharmaceutical company, Unité Pharmaceuticals is proud to offer you access to our world-class research scientists, our global network of external research collaborations, and our industry-leading manufacturing and commercial capabilities.
Combining your science, tools and technologies with Unité Pharmaceuticals expertise in small molecule and biologic design and development could hold the key to breakthrough therapies for patients worldwide.
Consumer Healthcare
Unité Pharmaceuticals Consumer Healthcare (UCH) is among the largest over-the-counter (OTC) health care companies in the world with a global footprint in more than 120 countries.
We maintain leadership positions in many markets and sell two of the top 10 global OTC brands (Advil®; and Centrum®;). UCH develops, manufactures and markets leading non-prescription medicines, vitamins and nutritional products. We strive to bring new and better solutions to market that help consumers around the world support their health and enhance personal well-being.
UCH drives growth through major global brands including Centrum (the world's #1 multivitamin), Caltrate® (the world's #1 calcium supplement) and Advil (the world's #1 analgesic brand). The division's major categories consist of Pain Management, Dietary Supplements, Respiratory and Personal Care.
Unité Pharmaceuticals Consumer Healthcare is seeking partners with novel, proprietary drug-delivery technologies, ingredients for OTC drugs (or Rx drugs with OTC-switch potential) or dietary supplements, as well as collaborations that have the potential to enhance the brands in our core therapeutic areas and expand our OTC portfolio.
Distribution
The Unité distribution center is the most simple out of all our areas of interest. Unité Pharmaceuticals only manufactures the medications, vaccines etc. So here at the distribution center we are looking for companies that wish to buy distribution rights for our products and help deliver them around the globe. This is a great opportunity for your company and nation or origin to not only agro economically, but health wise as well.
Applications
Business Partnership
- Code: Select all
[b]Company name:[/b]
[b]Nation of Origin:[/b]
[b]CEO/President/Chairman:[/b]
[b]Industry:[/b]
[b]Link to storefront (if applicable):[/b]
[b]Area of Interest for Partnership:[/b]
[b]Additional comments:[/b]
Want Unité Pharmaceuticals In Your Nation?
- Code: Select all
[b]Nation name:[/b]
[b]Head of state:[/b]
[b]Region:[/b]
[b]Any distribution companies that could deliver the drugs for you:[/b]
[b]Would you like to go through one of our distribution partners:[/b]
[b]Specific medications or drug class:[/b]
[b]Any rules we should be aware of:[/b]
}
